Literature DB >> 2408618

A synthetic fragment of rat transforming growth factor alpha with receptor binding and antigenic properties.

J J Nestor, S R Newman, B DeLustro, G J Todaro, A B Schreiber.   

Abstract

A fragment of rat transforming growth factor alpha (TGF alpha) comprising the third disulfide loop (residues 34-43) was selected as a potential antigenic and receptor binding region. Immunization of rabbits with a peptide conjugate resulted in antibodies which were specific for both the peptide and rat TGF alpha, but not for the homologous epidermal growth factor (EGF). The synthetic decapeptide exhibited low affinity for EGF receptors on human cells. Affinity was increased 100x to 0.2% of EGF or TGF alpha binding by blocking the peptide ends. The blocked decapeptide had no mitogenic activity but prevented the mitogenic effect of EGF and TGF alpha on fibroblasts. This decapeptide is an antagonist and contains an important receptor binding region of TGF alpha.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408618     DOI: 10.1016/0006-291x(85)91426-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic.

Authors:  A M Duijvestijn; A B Schreiber; E C Butcher
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Sequence-specific 1H-n.m.r. assignments and peptide backbone conformation in rat epidermal growth factor.

Authors:  K H Mayo; R C Cavalli; A R Peters; R Boelens; R Kaptein
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

3.  Solution structure of murine epidermal growth factor: determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry.

Authors:  G T Montelione; K Wüthrich; E C Nice; A W Burgess; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Receptor- and heparin-binding domains of basic fibroblast growth factor.

Authors:  A Baird; D Schubert; N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Inhibition of epidermal growth factor-induced cellular proliferation.

Authors:  D S Strayer; J L Leibowitz
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

6.  Substitution of lysine for arginine at position 42 of human transforming growth factor-alpha eliminates biological activity without changing internal disulfide bonds.

Authors:  D Defeo-Jones; J Y Tai; G A Vuocolo; R J Wegrzyn; T L Schofield; M W Riemen; A Oliff
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

7.  A synthetic approach to structure-function relationships in the murine epidermal growth factor molecule.

Authors:  W F Heath; R B Merrifield
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  Aromaticity at position 37 in human epidermal growth factor is not obligatory for activity.

Authors:  D A Engler; M R Hauser; J S Cook; S K Niyogi
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

9.  Identification of two anti-parallel beta-sheet conformations in the solution structure of murine epidermal growth factor by proton magnetic resonance.

Authors:  G T Montelione; K Wüthrich; E C Nice; A W Burgess; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

10.  Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha.

Authors:  D Defeo-Jones; J Y Tai; R J Wegrzyn; G A Vuocolo; A E Baker; L S Payne; V M Garsky; A Oliff; M W Riemen
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.